Ambrosia Bio
PrivateLast Round
Series A
Dec 10, 2024
Est. Valuation
$39.75M
Total Funding Raised
$25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ambrosia Bio is a biotechnology company that offers an enzyme-based technology for producing allulose, a low-calorie sugar substitute.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambrosia Bio Comparables
Compare Ambrosia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonumose, Inc. | 81% | |
| Prodalim | 70% | |
| Amai Proteins | 68% | |
Ambrosia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2024 |
Ambrosia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BVF Partners L.P. | Series A |
| Boulder Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 50% MoM.
- May 17, 2026
Monthly visitors grew 122% MoM, reaching 1.2K.
Ambrosia Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ambrosia Bio's valuation, stock price, and market status.